Our COVID-19 Solutions Portal has captured nearly 200 innovations. Working with our government partners- DBEI, DoH, HSE and EI many of these solutions have now been implemented to support healthcare during the pandemic. Here’s a sample of just a few of these solutions in action.
On the 8th of May 2020 Health Innovation Hub Ireland held a webinar entitled “COVID-19- Challenges and Opportunities for the Medtech Industry”. The webinar was presented by David Scott, Senior Associate with BHSM Solicitors who works in the Healthcare and Life Sciences Department.
Throughout the webinar David provided a brief overview of the medtech regulatory landscape pre COVID-19. He discussed the responses to COVID-19 from both regulatory and industry perspectives while he also spoke about the challenges and opportunities for the medtech industry post COVID-19.
We would like to thank David for delivering this webinar and anyone who viewed the webinar on the day.
Public Sector Healthcare & Education Members,
Please see below details on our Masterclass in Digital Health Solutions event, which is now being moved to an online format.
Ibec’s Connected Health Skillnet, together with Irish Medtech Association, will host a number of short online meetings over the coming months to share expert insights on how technology is influencing the future of healthcare in Ireland and beyond.
The first event will focus on Digital Health in the Age of COVID-19 where we will discuss some of the Irish innovations that are responding to Coronavirus and how digital health can be a critical tool in the diagnosis, treatment and management of healthcare during times of crisis and beyond. Please see event details below.
Date: Thursday, 14th May 2020
Time: 11:00 – 12:00 (1 hour)
Venue: Online – a link to join the online meeting will be sent after registration.
- Eamonn Costello, Co-Founder & CEO, patientMpower
patientMpower is a digital healthcare company providing technology solutions for people living with long term illness. The company has developed a remote monitoring solution which enables remote monitoring of otherwise healthy patients with mild to moderate COVID-19 symptoms who are in self-isolation in order to preserve capacity in hospitals for those with more severe symptoms or underlying conditions.
- Jim O’Donoghue, President, S3 Connected Health
S3 Connected Health partners with pharma, medtech, and healthcare providers to create and operate digital health solutions and connected medical devices that improve the lives of people with acute and chronic conditions. In response to COVID-19 the company has developed ACORRD, a web-based application, helps support healthcare professionals with triage, monitoring, and treatment of patients in-hospital, as the coronavirus pandemic continues.
We would be delighted if you or a colleague is free to join us.
Register your place at this (free) forum event here: https://www.irishmedtechassoc.ie/IBEC/Event~digital-health-forum **Registration closes 12th May**
Eoghan Ó Faoláin Jennifer McCormack
Head of Public Sector Accounts, Ibec Irish Medtech Association Network Executive
Eircode: D02 H720 Connected Health Skillnet Network Manager
Phone: +353 1 605 1656 / +353 86 0215947 T: +353 1 605 1537
Equipment to make it easier and safer for patients with COVID-19 to breathe
Lead Researchers: Professor Martin O’Halloran and Professor John Laffey, NUI Galway
Science Foundation Ireland award €205,667
The virus that causes COVID-19 attacks the airways and lungs, which means that people who are ill with the virus can have trouble breathing.
There are pieces of equipment to help these patients, including machines to assist their breathing, and tubes to deliver a flow of oxygen into their nose. Because of COVID-19 though, such equipment is in short supply, and in the case of high-flow oxygen, it may put the attending healthcare workers at greater risk of being exposed to the virus.
A new project led by NUI Galway called INSPIRE will develop new and easy-to-manufacture equipment to help support patients with airway problems while minimising the risk to healthcare workers.
What is the issue?
Patients with COVID-19 who are severely ill often need help to breathe, but equipment to do this is in short supply, and some may increase the risk of the virus spreading to healthcare workers.
What will the research project do?
The INSPIRE project led by NUI Galway will develop a CPAP/BiPAP Hood that can help patients to breathe and that will be easy to manufacture and reuse, and comfortable for patients to use for long periods.
For patients receiving high-flow oxygen therapy, the project will also develop a vacuum-assisted face guard that will collect infectious droplets coming from the patient’s nose or mouth during treatment, reducing the infection risk for healthcare workers.
The initiative will involve an interdisciplinary team of academic researchers, MedTech engineers, frontline healthcare professionals and industry working together to develop these technologies.
What will the potential impact be?
By developing breathing-support equipment that is easy to manufacture and safe to use for patients with COVID-19, the project will reduce risk of infection to front-line healthcare staff and may help reduce the demand on more invasive, mechanical ventilators for patients.
Dr Martin O’Halloran, Director of the Translational Medical Device Laboratory at NUI Galway, says:
This project shows what can be achieved when industry, academia and the HSE come together with a common goal of saving lives during the COVID-19 crisis. Uniquely, the Inspire team is composed of several founders of Irish MedTech companies, a team of NUI Galway researchers, and clinicians and healthcare workers from UHG. The glue holding this diverse team together is a shared commitment to making a real and tangible impact on patient care.”
Originally published by Department of the Taoiseach. Full award list here
Health Innovation Hub Ireland is delighted to announce that David Scott, BHSM Solicitors, will deliver a webinar entitled “COVID-19- Challenges and Opportunities for the Medtech Industry”.
Have a question: Join Slido with the event code 31775
Contact: Eimer O’Connell, HIHI, (email@example.com)
National patent offices, where patent applications are filed and granted, are implementing measures to reflect the rapid changes to the business environment. Recognising that timelines may be affected by these workplace shifts some allowances have been introduced. Here KTI shares an overview of some of those extensions. As the situation is ever-changing, we recommend that those affected visit individual office websites to confirm updates or make contact as directed.
Intellectual Property Office of Ireland
The IPOI has announced it will remain closed from 13th March until Sunday 19th April 2020 for the transaction of business with the public. Consequently, these days are deemed to be “excluded days” for all purposed under the Acts and Rules.
Following the Government announcement on 27th March 2020 of further measures aimed at controlling the spread of Covid 19 virus, IPOI staff working remotely will continue to maintain all of its online and e-services including e-filing of applications, electronic fee payments and email enquiries during normal working hours until further notice. However IPOI staff will not be able to deal with telephone enquiries. For more information visit the IPOI website.
European Patents Office
The EPO is the patent office for Europe. The EPO has advised all time limits expiring on or after 15 March 2020 have been extended to 17 April 2020. Further information on this an other implications of COVID-19 can be found on the EPO’s dedicated page relating to Coronavirus updates.
European Intellectual Property Office
The EUIPO is the European Union Intellectual Property Office responsible for managing the EU trademark and the registered Community design. The EUIPO has issued a statement extending all time limits to 1 May 2020. In practice this means time limits are extended until Monday 4th May as Friday 1st May is a public holiday. Full details on the nature of this extension can be accessed here where any further updates are also likely to be announced.
UK Intellectual Property Office
The UK IPO has declared 24 March, and subsequent days until further notice, interrupted days. This means that any deadlines for patents, supplementary protection certificates, trade marks, designs, and applications for these rights, which fall on an interrupted day will be extended until the IPO notifies the end of the interrupted days period. To support rights holders, businesses and IP professionals plan ahead the UK IPO will provide a minimum of 2 weeks’ notice before ending the interrupted days period. The latest news can be found here.
United States Patent and Trademark Office
The USPTO has announced extensions to the time allowed to file certain patent and trademark-related documents and to pay certain required fees. The details for patents and trademarks are quite detailed and more information is available here.
WIPO World Intellectual Property Organisation
WIPO has announced some lee way in relation to international trademark matters although extensions will not be granted automatically as is the case in other offices. Rather WIPO users must provide sufficient evidence to excuse the delay. On April 7, WIPO Director General will deliver a public broadcase which will include some information on the management of Covid-19 and its impact on WIPO services and programs. For more detail visit the WIPO website.
HIHI Postgraduate Diploma in Healthcare Innovation
The HIHI/TCD Postgraduate Diploma in Healthcare Innovation is unaffected and will continue delivering online. If you need more information, please contact the Course Coordinator: Michelle Armstrong – firstname.lastname@example.org.
Entering its second year, the Postgraduate is now open for applications for the 2020/21 cohort. There are a limited number of scholarships available to HSE staff. More here.
HIHI Innovation Workshops
The final HIHI Workshop in the series, is postponed for now, due to the current health situation. Many of the attendees are working directly in this situation. HIHI is keen that each should have the opportunity to complete the HIHI workshop series. As a result, Workshop 5 – the presentation workshop, is postponed until further notice.
If you have any questions in the meantime: email@example.com
Research and Innovation, in health, academia and industry, have a significant role to play in the national and global response to COVID-19. Consequently, the Government’s main research and innovation agencies have developed a coordinated Rapid Response Research and Innovation programme to help mitigate and manage the COVID-19 pandemic by unlocking the potential of Irish based researchers and innovators to join the global efforts.
This coordinated response is comprised of two complementary strands. Having two focus areas allows for sufficient specialisation and coordination while optimising available resources.
- The first focus area targets medical countermeasures, health service readiness, and social and policy countermeasures to COVID-19. This is led by The Heath Research Board and the Irish Research Council. Details of the call can be found here.
- The second focus area is an agile and adaptive initiative to combine the capabilities of industry and academia in the development of innovative solutions that can have a rapid demonstrable impact on the current COVID-19 crisis in Ireland. This is led by Science Foundation Ireland, Enterprise Ireland and IDA Ireland and details of the call can be found here.
The agencies will work in partnership to coordinate applications and ensure a seamless and agile review and funding process, with the progress and results from each stream shared broadly. As the calls operate under a single programme, applications will be aligned by the agencies to the most appropriate call.
In dealing with the COVID-19 crisis, pace is critical and research funders around the globe have mobilised rapidly to provide a range of opportunities for researchers and innovative companies. The Rapid Response Research and Innovation funding proposal is an invitation to researchers and innovators in Ireland to support the efforts to reduce the impact of COVID-19.